€410.80
Your prediction
Vertex Pharmaceuticals Inc. Stock
Pros and Cons of Vertex Pharmaceuticals Inc. in the next few years
Pros
Cons
Performance of Vertex Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.770% | 1.395% | 8.677% | -11.608% | 5.863% | 49.708% | 74.031% |
| Regeneron Pharmaceuticals Inc. | 0.250% | -0.226% | 8.979% | -51.284% | -28.223% | -14.675% | -9.014% |
| Exact Sciences | -0.730% | -0.389% | -9.179% | -4.921% | -24.669% | -7.140% | -50.507% |
| Incyte Corp. | 1.610% | 12.983% | 17.399% | 8.262% | 3.287% | -10.696% | -19.981% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When evaluating the financial position of Vertex Pharmaceuticals Inc. (symbol: VRTX), it is evident that the company exhibits robust financial health, especially for a player in the Biotechnology & Medical Research sector. As observed from the provided financial statements, Vertex demonstrates strong revenue growth, impressive profitability, and significant cash reserves. This overall positive trend is accompanied by notable investment in research and development, which is critical for sustaining innovation in the biotech field. However, like any investment, a deeper dive into the various financial metrics is essential to identify both advantages and drawbacks.
Strong Revenue Generation: Vertex reported a total revenue of approximately $9.87 billion for 2023, showcasing healthy growth compared to previous years. The quarterly revenue growth rate of 13.3% indicates consistent demand for its products, which is promising for future sales and market expansion.
Impressive Profit Margins: The profit margin stands at around 39.5%, highlighting Vertex's ability to convert sales into profits effectively. Coupled with an operating margin of 45.2%, it reflects efficient management of operational expenses relative to revenue.
Comments
News
The 3 Things That Matter for Vertex Pharmaceuticals Now
Vertex Pharmaceuticals (NASDAQ: VRTX) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and
The Best Stocks to Invest $1,000 in Right Now
What if you only had $1,000 to invest in stocks and had to put the money to work today? Which stocks would you buy? That's admittedly not an easy question to answer. I can think of lots of stocks
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
You're unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night because of their high volatility and risk. The good news, though, is that